Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

Clinical trial NCT01664624 · COMPLETED

Trial details

NCT number: NCT01664624
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2012-07-01
Primary completion: 2012-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.